beta

AEZS

Aeterna Zentaris Inc.

Aezs

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

03-25-2019 after market close 03-25-2019 after market close 03-25-2019 after market close 03-25-2019 after market close 03-25-2019 after market close 03-25-2019 after market close 03-25-2019 after market close 03-25-2019 after market close 03-25-2019 after market close 11-06-2018 after market close 08-09-2018 after market close 05-07-2018 after market close 03-28-2018 after market close 11-08-2017 after market close 08-10-2017 after market close 05-08-2017 after market close
Actual EPS -0.31 -0.31 -0.31 -0.31 -0.31 -0.31 -0.31 -0.31 -0.31 -0.15 -0.16 0.87 -0.24 -0.44 -0.46 -0.31
Consensus EPS -0.19 -0.19 -0.19 -0.19 -0.19 -0.19 -0.19 -0.19 -0.19 -0.25 -0.32 -0.09 -0.37 -0.41 -0.41 -0.33
Estimated EPS -0.19 -0.19 -0.19 -0.19 -0.19 -0.19 -0.19 -0.19 -0.19 -0.25 -0.32 -0.09 -0.37 -0.41 -0.41 -0.33
Number of Estimates 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
EPS Surprise -$0.12 -$0.12 -$0.12 -$0.12 -$0.12 -$0.12 -$0.12 -$0.12 -$0.12 $0.10 $0.16 $0.96 $0.13 -$0.03 -$0.05 $0.02

Stats

Summary

AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing novel treatments in oncology, endocrinology and women's health.

Market Cap: 39.3 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.aezsinc.com

Shares Outstanding: 16.4 Million

Float: 16.4 Million

Dividend: 0.0 (0.0%)

Beta: 0.694462

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 798 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1603 trading days

From: 2013-01-29 To: 2019-06-12

Lowest Point:

Microcaps mostly among midday movers

via: SeekingAlpha at 2019-06-13 08:41:38:000

Gainers: Coda Octopus Group (NASDAQ: CODA ) +40% . Mmtec (NASDAQ: MTC ) +30% . Red Robin Gourmet Burgers (NASDAQ: RRGB ) +29% . DryShips (NASDAQ: DRYS ) +24% . Cemtrex (NASDAQ: CETX ) +21% . Ruhnn Holding Limited (NASDAQ: RUHN ) +21% . RH (NYSE: RH ) +20% . Aeterna Zentaris (N… read more...

BYND, ZM, JAGX and DOMO among notable midday movers

via: SeekingAlpha at 2019-06-07 08:58:33:000

Gainers: Stewardship Financial (NASDAQ: SSFN ) +73% . Beyond Meat (NASDAQ: BYND ) +36% . La Jolla Pharmaceutical (NASDAQ: LJPC ) +25% . ReWalk Robotics (NASDAQ: RWLK ) +26% . Neptune Wellness Solutions (NASDAQ: NEPT ) +21% . Zoom Video Communications (NASDAQ: ZM ) +21% . Horizo… read more...

BYND, ZM, JAGX and DOMO among notable midday movers

via: SeekingAlpha at 2019-06-07 08:58:33:000

Gainers: Stewardship Financial (NASDAQ: SSFN ) +73% . Beyond Meat (NASDAQ: BYND ) +36% . La Jolla Pharmaceutical (NASDAQ: LJPC ) +25% . ReWalk Robotics (NASDAQ: RWLK ) +26% . Neptune Wellness Solutions (NASDAQ: NEPT ) +21% . Zoom Video Communications (NASDAQ: ZM ) +21% . Horizo… read more...

BYND, ZM, JAGX and DOMO among notable midday movers

via: SeekingAlpha at 2019-06-07 08:58:33:000

Gainers: Stewardship Financial (NASDAQ: SSFN ) +73% . Beyond Meat (NASDAQ: BYND ) +36% . La Jolla Pharmaceutical (NASDAQ: LJPC ) +25% . ReWalk Robotics (NASDAQ: RWLK ) +26% . Neptune Wellness Solutions (NASDAQ: NEPT ) +21% . Zoom Video Communications (NASDAQ: ZM ) +21% . Horizo… read more...

BYND, ZM, JAGX and DOMO among notable midday movers

via: SeekingAlpha at 2019-06-07 08:58:33:000

Gainers: Stewardship Financial (NASDAQ: SSFN ) +73% . Beyond Meat (NASDAQ: BYND ) +36% . La Jolla Pharmaceutical (NASDAQ: LJPC ) +25% . ReWalk Robotics (NASDAQ: RWLK ) +26% . Neptune Wellness Solutions (NASDAQ: NEPT ) +21% . Zoom Video Communications (NASDAQ: ZM ) +21% . Horizo… read more...

BYND, ZM, JAGX and DOMO among notable midday movers

via: SeekingAlpha at 2019-06-07 08:58:33:000

Gainers: Stewardship Financial (NASDAQ: SSFN ) +73% . Beyond Meat (NASDAQ: BYND ) +36% . La Jolla Pharmaceutical (NASDAQ: LJPC ) +25% . ReWalk Robotics (NASDAQ: RWLK ) +26% . Neptune Wellness Solutions (NASDAQ: NEPT ) +21% . Zoom Video Communications (NASDAQ: ZM ) +21% . Horizo… read more...

AEterna Zentaris: A Slow Bleed After Vexing Q1 Earnings

via: SeekingAlpha at 2019-06-03 17:23:15:000

AEterna Zentaris ( AEZS ) recently reported an abysmal Q1 earnings report that revealed the company only received $0.04 million in royalty revenue, which was a bit of a headscratcher seeing that the expected revenue was over $4 million. One would think there would be a strong sell-off when a c… read more...

AEterna Zentaris: A Slow Bleed After Vexing Q1 Earnings

via: SeekingAlpha at 2019-06-03 17:23:15:000

AEterna Zentaris ( AEZS ) recently reported an abysmal Q1 earnings report that revealed the company only received $0.04 million in royalty revenue, which was a bit of a headscratcher seeing that the expected revenue was over $4 million. One would think there would be a strong sell-off when a c… read more...

AEterna Zentaris: A Slow Bleed After Vexing Q1 Earnings

via: SeekingAlpha at 2019-06-03 17:23:15:000

AEterna Zentaris ( AEZS ) recently reported an abysmal Q1 earnings report that revealed the company only received $0.04 million in royalty revenue, which was a bit of a headscratcher seeing that the expected revenue was over $4 million. One would think there would be a strong sell-off when a c… read more...

Aeterna Zentaris misses by $0.34, misses on revenue

via: SeekingAlpha at 2019-05-07 13:45:57:000

Aeterna Zentaris (NASDAQ: AEZS ): Q1 GAAP EPS of -$0.30 misses by $0.34 . Revenue of $0.04M (-99.8% Y/Y) misses by $4.16M . Press Release More news on: Aeterna Zentaris Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Aeterna Zentaris misses by $0.34, misses on revenue

via: SeekingAlpha at 2019-05-07 13:45:57:000

Aeterna Zentaris (NASDAQ: AEZS ): Q1 GAAP EPS of -$0.30 misses by $0.34 . Revenue of $0.04M (-99.8% Y/Y) misses by $4.16M . Press Release More news on: Aeterna Zentaris Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Aeterna Zentaris misses by $0.34, misses on revenue

via: SeekingAlpha at 2019-05-07 13:45:57:000

Aeterna Zentaris (NASDAQ: AEZS ): Q1 GAAP EPS of -$0.30 misses by $0.34 . Revenue of $0.04M (-99.8% Y/Y) misses by $4.16M . Press Release More news on: Aeterna Zentaris Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Winning Bounce/Lag Momentum Stocks For Week 16 Of 2019 (4/15-4/19)

via: SeekingAlpha at 2019-04-15 01:06:32:000

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc… read more...

Winning Bounce/Lag Momentum Stocks For Week 16 Of 2019 (4/15-4/19)

via: SeekingAlpha at 2019-04-15 01:06:32:000

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc… read more...

Winning Bounce/Lag Momentum Stocks For Week 16 Of 2019 (4/15-4/19)

via: SeekingAlpha at 2019-04-15 01:06:32:000

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc… read more...

Winning Bounce/Lag Momentum Stocks For Week 15 Of 2019 (4/8-4/12)

via: SeekingAlpha at 2019-04-08 17:20:54:000

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts. Winning Bounce/Lag Momentum Stocks fo… read more...

Winning Bounce/Lag Momentum Stocks For Week 15 Of 2019 (4/8-4/12)

via: SeekingAlpha at 2019-04-08 17:20:54:000

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts. Winning Bounce/Lag Momentum Stocks fo… read more...

Winning Bounce/Lag Momentum Stocks For Week 15 Of 2019 (4/8-4/12)

via: SeekingAlpha at 2019-04-08 17:20:54:000

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts. Winning Bounce/Lag Momentum Stocks fo… read more...

Healthcare Breakout Beat 2018 Forecast: How High Will It Go In 2019?

via: SeekingAlpha at 2019-04-05 07:28:20:000

From the Big Picture to Individual Stock Breakouts Last year I highlighted the Healthcare Biotech Sector Breakout and correctly forecasted "at least 20% gains in sector ETFs and even higher for many key biotech stocks in the near term." I believe the technical analysis that I will det… read more...

Healthcare Breakout Beat 2018 Forecast: How High Will It Go In 2019?

via: SeekingAlpha at 2019-04-05 07:28:20:000

From the Big Picture to Individual Stock Breakouts Last year I highlighted the Healthcare Biotech Sector Breakout and correctly forecasted "at least 20% gains in sector ETFs and even higher for many key biotech stocks in the near term." I believe the technical analysis that I will det… read more...

Healthcare Breakout Beat 2018 Forecast: How High Will It Go In 2019?

via: SeekingAlpha at 2019-04-05 07:28:20:000

From the Big Picture to Individual Stock Breakouts Last year I highlighted the Healthcare Biotech Sector Breakout and correctly forecasted "at least 20% gains in sector ETFs and even higher for many key biotech stocks in the near term." I believe the technical analysis that I will det… read more...

Healthcare Breakout Beat 2018 Forecast: How High Will It Go In 2019?

via: SeekingAlpha at 2019-04-05 07:28:20:000

From the Big Picture to Individual Stock Breakouts Last year I highlighted the Healthcare Biotech Sector Breakout and correctly forecasted "at least 20% gains in sector ETFs and even higher for many key biotech stocks in the near term." I believe the technical analysis that I will det… read more...

Winning Bounce/Lag Momentum Stocks For Week 14 Of 2019 (4/1-4/5)

via: SeekingAlpha at 2019-04-02 07:04:15:000

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his 2% trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts. Winning Bounce/Lag Momentum Stocks… read more...

Winning Bounce/Lag Momentum Stocks For Week 14 Of 2019 (4/1-4/5)

via: SeekingAlpha at 2019-04-02 07:04:15:000

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his 2% trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts. Winning Bounce/Lag Momentum Stocks… read more...

Winning Bounce/Lag Momentum Stocks For Week 14 Of 2019 (4/1-4/5)

via: SeekingAlpha at 2019-04-02 07:04:15:000

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his 2% trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts. Winning Bounce/Lag Momentum Stocks… read more...

AEterna Zentaris Stockholders Enjoy Recent Company Developments

via: SeekingAlpha at 2019-03-28 05:17:06:000

AEterna Zentaris ( AEZS ) has achieved European approval for their adult growth hormone deficiency "GHD" drug Macrilen (macimorelin). Investors expected a subsequent partner announcement to market Macrilen throughout Europe. However, a recent press release announced that the board of dir… read more...

AEterna Zentaris Stockholders Enjoy Recent Company Developments

via: SeekingAlpha at 2019-03-28 05:17:06:000

AEterna Zentaris ( AEZS ) has achieved European approval for their adult growth hormone deficiency "GHD" drug Macrilen (macimorelin). Investors expected a subsequent partner announcement to market Macrilen throughout Europe. However, a recent press release announced that the board of dir… read more...

AEterna Zentaris Stockholders Enjoy Recent Company Developments

via: SeekingAlpha at 2019-03-28 05:17:06:000

AEterna Zentaris ( AEZS ) has achieved European approval for their adult growth hormone deficiency "GHD" drug Macrilen (macimorelin). Investors expected a subsequent partner announcement to market Macrilen throughout Europe. However, a recent press release announced that the board of dir… read more...

Aeterna Zentaris beats on revenue

via: SeekingAlpha at 2019-03-26 13:24:31:000

Aeterna Zentaris (NASDAQ: AEZS ): Q4 GAAP EPS of -$0.31. More news on: Aeterna Zentaris Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more … read more...

Aeterna Zentaris beats on revenue

via: SeekingAlpha at 2019-03-26 13:24:31:000

Aeterna Zentaris (NASDAQ: AEZS ): Q4 GAAP EPS of -$0.31. More news on: Aeterna Zentaris Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more … read more...

Momentum Strategies That Continue To Dominate Through January

via: SeekingAlpha at 2019-01-17 16:24:11:000

The 20 stocks in the Premium Portfolio from my membership service that draws from a wide range of different models in the financial literature has surged to 15% gains through January. These gains again appear to be primarily based on the strength of momentum and forensic negative stock selecti… read more...

Momentum Strategies That Continue To Dominate Through January

via: SeekingAlpha at 2019-01-17 16:24:11:000

The 20 stocks in the Premium Portfolio from my membership service that draws from a wide range of different models in the financial literature has surged to 15% gains through January. These gains again appear to be primarily based on the strength of momentum and forensic negative stock selecti… read more...

Momentum Strategies That Continue To Dominate Through January

via: SeekingAlpha at 2019-01-17 16:24:11:000

The 20 stocks in the Premium Portfolio from my membership service that draws from a wide range of different models in the financial literature has surged to 15% gains through January. These gains again appear to be primarily based on the strength of momentum and forensic negative stock selecti… read more...

Story Starting To Change For AEterna Zentaris

via: SeekingAlpha at 2019-01-03 08:30:00:000

AEterna Zentaris ( AEZS ) is waiting for a final decision from the European Commission ((EC)) for their adult growth hormone deficiency drug Macrilen (macimorelin). Recently, the company received positive feedback from the Committee for Medicinal Products for Human Use ((CHMP)), and should h… read more...

Story Starting To Change For AEterna Zentaris

via: SeekingAlpha at 2019-01-03 08:30:00:000

AEterna Zentaris ( AEZS ) is waiting for a final decision from the European Commission ((EC)) for their adult growth hormone deficiency drug Macrilen (macimorelin). Recently, the company received positive feedback from the Committee for Medicinal Products for Human Use ((CHMP)), and should h… read more...

Story Starting To Change For AEterna Zentaris

via: SeekingAlpha at 2019-01-03 08:30:00:000

AEterna Zentaris ( AEZS ) is waiting for a final decision from the European Commission ((EC)) for their adult growth hormone deficiency drug Macrilen (macimorelin). Recently, the company received positive feedback from the Committee for Medicinal Products for Human Use ((CHMP)), and should h… read more...

VIPS, BZUN among premarket gainers

via: SeekingAlpha at 2018-12-03 09:25:27:000

Tesaro (NASDAQ: TSRO ) +59% on acquisition by Glaxo for $75. More news on: Tesaro, Global Blood Therapeutics, Hudson Technologies, Inc., Stocks on the move, , Read more … read more...

VIPS, BZUN among premarket gainers

via: SeekingAlpha at 2018-12-03 09:25:27:000

Tesaro (NASDAQ: TSRO ) +59% on acquisition by Glaxo for $75. More news on: Tesaro, Global Blood Therapeutics, Hudson Technologies, Inc., Stocks on the move, , Read more … read more...

VIPS, BZUN among premarket gainers

via: SeekingAlpha at 2018-12-03 09:25:27:000

Tesaro (NASDAQ: TSRO ) +59% on acquisition by Glaxo for $75. More news on: Tesaro, Global Blood Therapeutics, Hudson Technologies, Inc., Stocks on the move, , Read more … read more...

PCG, EIX and SONO among premarket gainers

via: SeekingAlpha at 2018-11-16 09:22:07:000

PG&E (NYSE: PCG ) +44% after California PUC to broaden probe including possible breakup. More news on: PG&E Corporation, Sonos, Inc., Edison International, Stocks on the move, , Read more … read more...

PCG, EIX and SONO among premarket gainers

via: SeekingAlpha at 2018-11-16 09:22:07:000

PG&E (NYSE: PCG ) +44% after California PUC to broaden probe including possible breakup. More news on: PG&E Corporation, Sonos, Inc., Edison International, Stocks on the move, , Read more … read more...

PCG, EIX and SONO among premarket gainers

via: SeekingAlpha at 2018-11-16 09:22:07:000

PG&E (NYSE: PCG ) +44% after California PUC to broaden probe including possible breakup. More news on: PG&E Corporation, Sonos, Inc., Edison International, Stocks on the move, , Read more … read more...

PCG, EIX and SONO among premarket gainers

via: SeekingAlpha at 2018-11-16 09:22:07:000

PG&E (NYSE: PCG ) +44% after California PUC to broaden probe including possible breakup. More news on: PG&E Corporation, Sonos, Inc., Edison International, Stocks on the move, , Read more … read more...

PCG, EIX and SONO among premarket gainers

via: SeekingAlpha at 2018-11-16 09:22:07:000

PG&E (NYSE: PCG ) +44% after California PUC to broaden probe including possible breakup. More news on: PG&E Corporation, Sonos, Inc., Edison International, Stocks on the move, , Read more … read more...

European advisory group backs Aeterna Zentaris' Macrilen; shares up 11% premarket

via: SeekingAlpha at 2018-11-16 09:01:18:000

Nano cap Aeterna Zentaris (NASDAQ: AEZS ) is up 11% premarket on increased volume on the heels of a positive opinion from an advisory group in Europe backing approval for MACRILEN (macimorelin) for the diagnosis of adult growth hormone deficiency. More news on: AEterna Zentar… read more...

European advisory group backs Aeterna Zentaris' Macrilen; shares up 11% premarket

via: SeekingAlpha at 2018-11-16 09:01:18:000

Nano cap Aeterna Zentaris (NASDAQ: AEZS ) is up 11% premarket on increased volume on the heels of a positive opinion from an advisory group in Europe backing approval for MACRILEN (macimorelin) for the diagnosis of adult growth hormone deficiency. More news on: AEterna Zentar… read more...

European advisory group backs Aeterna Zentaris' Macrilen; shares up 11% premarket

via: SeekingAlpha at 2018-11-16 09:01:18:000

Nano cap Aeterna Zentaris (NASDAQ: AEZS ) is up 11% premarket on increased volume on the heels of a positive opinion from an advisory group in Europe backing approval for MACRILEN (macimorelin) for the diagnosis of adult growth hormone deficiency. More news on: AEterna Zentar… read more...

European advisory group backs Aeterna Zentaris' Macrilen; shares up 11% premarket

via: SeekingAlpha at 2018-11-16 09:01:18:000

Nano cap Aeterna Zentaris (NASDAQ: AEZS ) is up 11% premarket on increased volume on the heels of a positive opinion from an advisory group in Europe backing approval for MACRILEN (macimorelin) for the diagnosis of adult growth hormone deficiency. More news on: AEterna Zentar… read more...

European advisory group backs Aeterna Zentaris' Macrilen; shares up 11% premarket

via: SeekingAlpha at 2018-11-16 09:01:18:000

Nano cap Aeterna Zentaris (NASDAQ: AEZS ) is up 11% premarket on increased volume on the heels of a positive opinion from an advisory group in Europe backing approval for MACRILEN (macimorelin) for the diagnosis of adult growth hormone deficiency. More news on: AEterna Zentar… read more...

Aeterna Zentaris, Inc. (AEZS) CEO Michael Ward on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-07 12:15:48:000

Aeterna Zentaris, Inc. (AEZS) Q3 2018 Earnings Conference Call November 06, 2018 08:30 AM ET Executives Michael Ward - President and Chief Executive Officer Leslie Auld - Senior Vice President and Chief Financial Officer Brian Garrison - Senior Vice President Corporate Developme… read more...

Aeterna Zentaris, Inc. (AEZS) CEO Michael Ward on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-07 12:15:48:000

Aeterna Zentaris, Inc. (AEZS) Q3 2018 Earnings Conference Call November 06, 2018 08:30 AM ET Executives Michael Ward - President and Chief Executive Officer Leslie Auld - Senior Vice President and Chief Financial Officer Brian Garrison - Senior Vice President Corporate Developme… read more...

Aeterna Zentaris, Inc. (AEZS) CEO Michael Ward on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-07 12:15:48:000

Aeterna Zentaris, Inc. (AEZS) Q3 2018 Earnings Conference Call November 06, 2018 08:30 AM ET Executives Michael Ward - President and Chief Executive Officer Leslie Auld - Senior Vice President and Chief Financial Officer Brian Garrison - Senior Vice President Corporate Developme… read more...

Aeterna Zentaris reports Q3 results

via: SeekingAlpha at 2018-11-07 08:13:25:000

Aeterna Zentaris (NASDAQ: AEZS ): Q3 GAAP EPS of -$0.15. Revenue of $0.66M (+175.0% Y/Y) Press Release More news on: AEterna Zentaris, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Aeterna Zentaris reports Q3 results

via: SeekingAlpha at 2018-11-07 08:13:25:000

Aeterna Zentaris (NASDAQ: AEZS ): Q3 GAAP EPS of -$0.15. Revenue of $0.66M (+175.0% Y/Y) Press Release More news on: AEterna Zentaris, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Aeterna Zentaris reports Q3 results

via: SeekingAlpha at 2018-11-07 08:13:25:000

Aeterna Zentaris (NASDAQ: AEZS ): Q3 GAAP EPS of -$0.15. Revenue of $0.66M (+175.0% Y/Y) Press Release More news on: AEterna Zentaris, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

ECA, SPOT and VECO among premarket losers on Q3 earnings

via: SeekingAlpha at 2018-11-01 09:18:38:000

Veeco Instruments (NASDAQ: VECO ) -32% on Q3 earnings . More news on: Veeco Instruments Inc., Ballard Power Systems, Inc., Encana Corporation, Stocks on the move, , Top stock market news, Read more … read more...

ECA, SPOT and VECO among premarket losers on Q3 earnings

via: SeekingAlpha at 2018-11-01 09:18:38:000

Veeco Instruments (NASDAQ: VECO ) -32% on Q3 earnings . More news on: Veeco Instruments Inc., Ballard Power Systems, Inc., Encana Corporation, Stocks on the move, , Top stock market news, Read more … read more...

ECA, SPOT and VECO among premarket losers on Q3 earnings

via: SeekingAlpha at 2018-11-01 09:18:38:000

Veeco Instruments (NASDAQ: VECO ) -32% on Q3 earnings . More news on: Veeco Instruments Inc., Ballard Power Systems, Inc., Encana Corporation, Stocks on the move, , Top stock market news, Read more … read more...

Healthcare & Tech leads midday movers (10/31/2018)

via: SeekingAlpha at 2018-10-31 12:39:55:000

More news on: Strongbridge Biopharma, AEterna Zentaris, Inc., Accuray Incorporated, Stocks on the move, , Read more … read more...

Aeterna Zentaris up 59% on Strongbridge/Novo Macrilen deal

via: SeekingAlpha at 2018-10-31 11:31:36:000

Thinly traded nano cap Aeterna Zentaris ( AEZS +58.5% ) is up on a whopping 159x surge in volume in reaction to Strongbridge Biopharma's ( SBBP +39.5% ) out-licensing deal with Novo Nordisk for U.S. and Canadian rights to MACRILEN (macimorelin). More news on: AEterna Zentaris, Inc., St… read more...

Aeterna Zentaris Inc.'s (AEZS) CEO Michael Ward on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-10 10:18:06:000

AEterna Zentaris, Inc. (AEZS) Q2 2018 Results Earnings Conference Call August 10, 2018, 08:30 AM ET Executives Michael Ward - CEO James Clavijo - CFO Nicola Ammer - Chief Medical Officer Brian Garrison - SVP, Global Commercial Operations Analysts Ramakanth Swayampakula - … read more...

Aeterna Zentaris Inc.'s (AEZS) CEO Michael Ward on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-10 10:18:06:000

AEterna Zentaris, Inc. (AEZS) Q2 2018 Results Earnings Conference Call August 10, 2018, 08:30 AM ET Executives Michael Ward - CEO James Clavijo - CFO Nicola Ammer - Chief Medical Officer Brian Garrison - SVP, Global Commercial Operations Analysts Ramakanth Swayampakula - … read more...

Aeterna Zentaris Inc.'s (AEZS) CEO Michael Ward on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-10 10:18:06:000

AEterna Zentaris, Inc. (AEZS) Q2 2018 Results Earnings Conference Call August 10, 2018, 08:30 AM ET Executives Michael Ward - CEO James Clavijo - CFO Nicola Ammer - Chief Medical Officer Brian Garrison - SVP, Global Commercial Operations Analysts Ramakanth Swayampakula - … read more...

Aeterna Zentaris Inc.'s (AEZS) CEO Michael Ward on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-10 10:18:06:000

AEterna Zentaris, Inc. (AEZS) Q2 2018 Results Earnings Conference Call August 10, 2018, 08:30 AM ET Executives Michael Ward - CEO James Clavijo - CFO Nicola Ammer - Chief Medical Officer Brian Garrison - SVP, Global Commercial Operations Analysts Ramakanth Swayampakula - … read more...

Aeterna Zentaris Inc.'s (AEZS) CEO Michael Ward on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-08-10 10:18:06:000

AEterna Zentaris, Inc. (AEZS) Q2 2018 Results Earnings Conference Call August 10, 2018, 08:30 AM ET Executives Michael Ward - CEO James Clavijo - CFO Nicola Ammer - Chief Medical Officer Brian Garrison - SVP, Global Commercial Operations Analysts Ramakanth Swayampakula - … read more...

Aeterna Zentaris beats by $0.16, misses on revenue

via: SeekingAlpha at 2018-08-09 16:58:31:000

Aeterna Zentaris (NASDAQ: AEZS ): Q2 EPS of -$0.16 beats by $0.16 . Revenue of $0.17M (-29.2% Y/Y) misses by $1.83M . Cash of $19.9M. Press Release More news on: AEterna Zentaris, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-06-15 15:31:40:000

Noteworthy events during the week of June 17 - 23 for healthcare investors. More news on: Matinas Biopharma Holdings, Inc., Valeant Pharmaceuticals International, Inc., Sarepta Therapeutics, Inc., Healthcare stocks news, , Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-06-15 15:31:40:000

Noteworthy events during the week of June 17 - 23 for healthcare investors. More news on: Matinas Biopharma Holdings, Inc., Valeant Pharmaceuticals International, Inc., Sarepta Therapeutics, Inc., Healthcare stocks news, , Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-06-15 15:31:40:000

Noteworthy events during the week of June 17 - 23 for healthcare investors. More news on: Matinas Biopharma Holdings, Inc., Valeant Pharmaceuticals International, Inc., Sarepta Therapeutics, Inc., Healthcare stocks news, , Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-06-15 15:31:40:000

Noteworthy events during the week of June 17 - 23 for healthcare investors. More news on: Matinas Biopharma Holdings, Inc., Valeant Pharmaceuticals International, Inc., Sarepta Therapeutics, Inc., Healthcare stocks news, , Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-06-15 15:31:40:000

Noteworthy events during the week of June 17 - 23 for healthcare investors. More news on: Matinas Biopharma Holdings, Inc., Valeant Pharmaceuticals International, Inc., Sarepta Therapeutics, Inc., Healthcare stocks news, , Read more … read more...

Midday Gainers / Losers (05/31/2018)

via: SeekingAlpha at 2018-05-31 12:45:31:000

Gainers: MDGL +141% . VKTX +68% . TPIV +24% . SESN +25% . CRIS +22% . VTVT +21% . JILL +21% . BOXL +19% . AXON +17% . I +17% . More news on: Madrigal Pharmaceuticals, Inc., Viking Therapeutics, TapImmune, Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/31/2018)

via: SeekingAlpha at 2018-05-31 12:45:31:000

Gainers: MDGL +141% . VKTX +68% . TPIV +24% . SESN +25% . CRIS +22% . VTVT +21% . JILL +21% . BOXL +19% . AXON +17% . I +17% . More news on: Madrigal Pharmaceuticals, Inc., Viking Therapeutics, TapImmune, Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (05/31/2018)

via: SeekingAlpha at 2018-05-31 12:45:31:000

Gainers: MDGL +141% . VKTX +68% . TPIV +24% . SESN +25% . CRIS +22% . VTVT +21% . JILL +21% . BOXL +19% . AXON +17% . I +17% . More news on: Madrigal Pharmaceuticals, Inc., Viking Therapeutics, TapImmune, Inc., Stocks on the move, , Read more … read more...

Week 22 Breakout Forecast: Short-Term Picks To Give You An Edge

via: SeekingAlpha at 2018-05-27 01:30:59:000

Breakout Forecast Selections for Week 22: Market conditions continue with high volatility. The positive momentum gauge spent another full week in yellow (medium) moving from a value of 73 last week down to a value of 57 this week. The all time low for the positive momentum selection gauge is… read more...

Week 22 Breakout Forecast: Short-Term Picks To Give You An Edge

via: SeekingAlpha at 2018-05-27 01:30:59:000

Breakout Forecast Selections for Week 22: Market conditions continue with high volatility. The positive momentum gauge spent another full week in yellow (medium) moving from a value of 73 last week down to a value of 57 this week. The all time low for the positive momentum selection gauge is… read more...

Week 22 Breakout Forecast: Short-Term Picks To Give You An Edge

via: SeekingAlpha at 2018-05-27 01:30:59:000

Breakout Forecast Selections for Week 22: Market conditions continue with high volatility. The positive momentum gauge spent another full week in yellow (medium) moving from a value of 73 last week down to a value of 57 this week. The all time low for the positive momentum selection gauge is… read more...

Week 22 Breakout Forecast: Short-Term Picks To Give You An Edge

via: SeekingAlpha at 2018-05-27 01:30:59:000

Breakout Forecast Selections for Week 22: Market conditions continue with high volatility. The positive momentum gauge spent another full week in yellow (medium) moving from a value of 73 last week down to a value of 57 this week. The all time low for the positive momentum selection gauge is… read more...

Aeterna Zentaris' (AEZS) CEO Michael V. Ward on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-08 12:02:04:000

Aeterna Zentaris Inc. (AEZS) Q1 2018 Results Earnings Conference Call May 08, 2018 08:30 AM ET Executives Michael V. Ward - CEO James Clavijo - CFO Analysts Olga Smolentseva - H.C. Wainwright Presentation Operator Greetings and welcome to Aeterna Zentaris Reports Fi… read more...

Aeterna Zentaris' (AEZS) CEO Michael V. Ward on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-08 12:02:04:000

Aeterna Zentaris Inc. (AEZS) Q1 2018 Results Earnings Conference Call May 08, 2018 08:30 AM ET Executives Michael V. Ward - CEO James Clavijo - CFO Analysts Olga Smolentseva - H.C. Wainwright Presentation Operator Greetings and welcome to Aeterna Zentaris Reports Fi… read more...

Aeterna Zentaris beats by $0.28, beats on revenue

via: SeekingAlpha at 2018-05-07 16:43:36:000

Aeterna Zentaris (NASDAQ: AEZS ): Q1 EPS of $0.87 beats by $0.28 . Revenue of $24.7M (N/M Y/Y) beats by $11.64M . Shares +9.5% . Press Release More news on: AEterna Zentaris, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...

Aeterna Zentaris beats by $0.28, beats on revenue

via: SeekingAlpha at 2018-05-07 16:43:36:000

Aeterna Zentaris (NASDAQ: AEZS ): Q1 EPS of $0.87 beats by $0.28 . Revenue of $24.7M (N/M Y/Y) beats by $11.64M . Shares +9.5% . Press Release More news on: AEterna Zentaris, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , read more...

Aeterna Zentaris' (AEZS) CEO Michael Ward on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-28 12:25:45:000

Aeterna Zentaris, Inc. (AEZS) Q4 2017 Results Earnings Conference Call March 28, 2018, 08:30 AM ET Executives Michael Ward - CEO James Clavijo - CFO Brian Garrison - SVP of Global Commercial Operations Nicola Ammer - Chief Medical Officer and VP of Clinical Development Analy… read more...

Aeterna Zentaris' (AEZS) CEO Michael Ward on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-28 12:25:45:000

Aeterna Zentaris, Inc. (AEZS) Q4 2017 Results Earnings Conference Call March 28, 2018, 08:30 AM ET Executives Michael Ward - CEO James Clavijo - CFO Brian Garrison - SVP of Global Commercial Operations Nicola Ammer - Chief Medical Officer and VP of Clinical Development Analy… read more...

AEterna Zentaris beats by $0.28, beats on revenue

via: SeekingAlpha at 2018-03-28 07:06:18:000

AEterna Zentaris (NASDAQ: AEZS ): Q4 EPS of -$0.03 beats by $0.28 . More news on: AEterna Zentaris, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

AEterna Zentaris beats by $0.28, beats on revenue

via: SeekingAlpha at 2018-03-28 07:06:18:000

AEterna Zentaris (NASDAQ: AEZS ): Q4 EPS of -$0.03 beats by $0.28 . More news on: AEterna Zentaris, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Your Daily Pharma Scoop: Genocea Surges, Gilead's Biktarvy, GlaxoSmithKline's Vaccine Succeeds In Late-Stage Study

via: SeekingAlpha at 2018-03-07 08:00:00:000

Analysis of top Seeking Alpha coverage: Genocea Biosciences Today, we will discuss Genocea Biosciences (GNCA), which is up sharply after a bullish note from Cantor Fitzgerald. In early trading, GNCA shares were up nearly 10%, offsetting some of the losses the company has incurred in 2018. Ye… read more...

Your Daily Pharma Scoop: Genocea Surges, Gilead's Biktarvy, GlaxoSmithKline's Vaccine Succeeds In Late-Stage Study

via: SeekingAlpha at 2018-03-07 08:00:00:000

Analysis of top Seeking Alpha coverage: Genocea Biosciences Today, we will discuss Genocea Biosciences (GNCA), which is up sharply after a bullish note from Cantor Fitzgerald. In early trading, GNCA shares were up nearly 10%, offsetting some of the losses the company has incurred in 2018. Ye… read more...

Midday Gainers / Losers (3/5/2018)

via: SeekingAlpha at 2018-03-05 12:45:39:000

Gainers: CLSD +36% . XL +29% . VCEL +28% . GTXI +23% . NIHD +16% . MRNS +14% . CASA +13% . OMEX +13% . IPI +12% . DAVE +12% . More news on: Clearside Biomedical, XL Group plc, Vericel Corporation, Stocks on the move, , Read more … read more...

Midday Gainers / Losers (3/5/2018)

via: SeekingAlpha at 2018-03-05 12:45:39:000

Gainers: CLSD +36% . XL +29% . VCEL +28% . GTXI +23% . NIHD +16% . MRNS +14% . CASA +13% . OMEX +13% . IPI +12% . DAVE +12% . More news on: Clearside Biomedical, XL Group plc, Vericel Corporation, Stocks on the move, , Read more … read more...

AEterna Zentaris: Licensing Agreement Takes Out Dilution Risk

via: SeekingAlpha at 2018-01-24 08:00:00:000

AEtarna Zentaris ( AEZS ) shares surged on Wednesday as the company announced a licensing agreement, which provides it with $24 million in upfront payment and takes out dilution risk. We have made adjustments to our model to reflect this agreement and are raising our price target on AEZS to … read more...

AEterna Zentaris: Licensing Agreement Takes Out Dilution Risk

via: SeekingAlpha at 2018-01-24 08:00:00:000

AEtarna Zentaris ( AEZS ) shares surged on Wednesday as the company announced a licensing agreement, which provides it with $24 million in upfront payment and takes out dilution risk. We have made adjustments to our model to reflect this agreement and are raising our price target on AEZS to … read more...

AEterna Zentaris: Licensing Agreement Takes Out Dilution Risk

via: SeekingAlpha at 2018-01-24 08:00:00:000

AEtarna Zentaris ( AEZS ) shares surged on Wednesday as the company announced a licensing agreement, which provides it with $24 million in upfront payment and takes out dilution risk. We have made adjustments to our model to reflect this agreement and are raising our price target on AEZS to … read more...

AEterna Zentaris: Licensing Agreement Takes Out Dilution Risk

via: SeekingAlpha at 2018-01-24 08:00:00:000

AEtarna Zentaris ( AEZS ) shares surged on Wednesday as the company announced a licensing agreement, which provides it with $24 million in upfront payment and takes out dilution risk. We have made adjustments to our model to reflect this agreement and are raising our price target on AEZS to … read more...

AEterna Zentaris: Licensing Agreement Takes Out Dilution Risk

via: SeekingAlpha at 2018-01-24 08:00:00:000

AEtarna Zentaris ( AEZS ) shares surged on Wednesday as the company announced a licensing agreement, which provides it with $24 million in upfront payment and takes out dilution risk. We have made adjustments to our model to reflect this agreement and are raising our price target on AEZS to … read more...

Biotech Forum Daily Digest For January 18th

via: SeekingAlpha at 2018-01-18 10:18:17:000

The greater danger for most of us lies not in setting our aim too high and falling short; but in setting our aim too low, and achieving our mark . Michelangelo Buonarroti The holiday shortened trading week has brought some volatility to Biotech Land. Tuesday we saw a earl… read more...

Biotech Forum Daily Digest For January 18th

via: SeekingAlpha at 2018-01-18 10:18:17:000

The greater danger for most of us lies not in setting our aim too high and falling short; but in setting our aim too low, and achieving our mark . Michelangelo Buonarroti The holiday shortened trading week has brought some volatility to Biotech Land. Tuesday we saw a earl… read more...

Biotech Forum Daily Digest For January 18th

via: SeekingAlpha at 2018-01-18 10:18:17:000

The greater danger for most of us lies not in setting our aim too high and falling short; but in setting our aim too low, and achieving our mark . Michelangelo Buonarroti The holiday shortened trading week has brought some volatility to Biotech Land. Tuesday we saw a earl… read more...

Biotech Forum Daily Digest For January 18th

via: SeekingAlpha at 2018-01-18 10:18:17:000

The greater danger for most of us lies not in setting our aim too high and falling short; but in setting our aim too low, and achieving our mark . Michelangelo Buonarroti The holiday shortened trading week has brought some volatility to Biotech Land. Tuesday we saw a earl… read more...

Biotech Forum Daily Digest For January 18th

via: SeekingAlpha at 2018-01-18 10:18:17:000

The greater danger for most of us lies not in setting our aim too high and falling short; but in setting our aim too low, and achieving our mark . Michelangelo Buonarroti The holiday shortened trading week has brought some volatility to Biotech Land. Tuesday we saw a earl… read more...

Your Daily Pharma Scoop: Juno Surges On Takeover Rumors, AEterna Zentaris Achieves Another Milestone, Spark Granted ODD

via: SeekingAlpha at 2018-01-18 08:00:00:000

Analysis of Top Seeking Alpha Coverage: Celgene/Juno Today we will discuss the market speculation about Celgene ( CELG ) looking for a target in the CAR-T space to boost its pipeline. The speculation began after a Wall Street Journal report and pushed Juno Therapeutics ( JUNO ) up more t… read more...

Your Daily Pharma Scoop: Juno Surges On Takeover Rumors, AEterna Zentaris Achieves Another Milestone, Spark Granted ODD

via: SeekingAlpha at 2018-01-18 08:00:00:000

Analysis of Top Seeking Alpha Coverage: Celgene/Juno Today we will discuss the market speculation about Celgene ( CELG ) looking for a target in the CAR-T space to boost its pipeline. The speculation began after a Wall Street Journal report and pushed Juno Therapeutics ( JUNO ) up more t… read more...

Your Daily Pharma Scoop: Juno Surges On Takeover Rumors, AEterna Zentaris Achieves Another Milestone, Spark Granted ODD

via: SeekingAlpha at 2018-01-18 08:00:00:000

Analysis of Top Seeking Alpha Coverage: Celgene/Juno Today we will discuss the market speculation about Celgene ( CELG ) looking for a target in the CAR-T space to boost its pipeline. The speculation began after a Wall Street Journal report and pushed Juno Therapeutics ( JUNO ) up more t… read more...

Your Daily Pharma Scoop: Juno Surges On Takeover Rumors, AEterna Zentaris Achieves Another Milestone, Spark Granted ODD

via: SeekingAlpha at 2018-01-18 08:00:00:000

Analysis of Top Seeking Alpha Coverage: Celgene/Juno Today we will discuss the market speculation about Celgene ( CELG ) looking for a target in the CAR-T space to boost its pipeline. The speculation began after a Wall Street Journal report and pushed Juno Therapeutics ( JUNO ) up more t… read more...

Your Daily Pharma Scoop: Juno Surges On Takeover Rumors, AEterna Zentaris Achieves Another Milestone, Spark Granted ODD

via: SeekingAlpha at 2018-01-18 08:00:00:000

Analysis of Top Seeking Alpha Coverage: Celgene/Juno Today we will discuss the market speculation about Celgene ( CELG ) looking for a target in the CAR-T space to boost its pipeline. The speculation began after a Wall Street Journal report and pushed Juno Therapeutics ( JUNO ) up more t… read more...

Midday Gainers / Losers (1/17/2018)

via: SeekingAlpha at 2018-01-17 12:49:46:000

Gainers: JUNO +49% . ORPN +24% . NURO +24% . AEZS +23% . XBIO +23% . PRTO +19% . ICHR +17% . FFHL +17% . MTSL +16% . ZAGG +14% . More news on: Juno Therapeutics, Bio Blast Pharma, NeuroMetrix, Inc., Stocks on the move, Read more … read more...

Midday Gainers / Losers (1/17/2018)

via: SeekingAlpha at 2018-01-17 12:49:46:000

Gainers: JUNO +49% . ORPN +24% . NURO +24% . AEZS +23% . XBIO +23% . PRTO +19% . ICHR +17% . FFHL +17% . MTSL +16% . ZAGG +14% . More news on: Juno Therapeutics, Bio Blast Pharma, NeuroMetrix, Inc., Stocks on the move, Read more … read more...

Midday Gainers / Losers (1/17/2018)

via: SeekingAlpha at 2018-01-17 12:49:46:000

Gainers: JUNO +49% . ORPN +24% . NURO +24% . AEZS +23% . XBIO +23% . PRTO +19% . ICHR +17% . FFHL +17% . MTSL +16% . ZAGG +14% . More news on: Juno Therapeutics, Bio Blast Pharma, NeuroMetrix, Inc., Stocks on the move, Read more … read more...

Midday Gainers / Losers (1/17/2018)

via: SeekingAlpha at 2018-01-17 12:49:46:000

Gainers: JUNO +49% . ORPN +24% . NURO +24% . AEZS +23% . XBIO +23% . PRTO +19% . ICHR +17% . FFHL +17% . MTSL +16% . ZAGG +14% . More news on: Juno Therapeutics, Bio Blast Pharma, NeuroMetrix, Inc., Stocks on the move, Read more … read more...

Midday Gainers / Losers (1/17/2018)

via: SeekingAlpha at 2018-01-17 12:49:46:000

Gainers: JUNO +49% . ORPN +24% . NURO +24% . AEZS +23% . XBIO +23% . PRTO +19% . ICHR +17% . FFHL +17% . MTSL +16% . ZAGG +14% . More news on: Juno Therapeutics, Bio Blast Pharma, NeuroMetrix, Inc., Stocks on the move, Read more … read more...

Premarket Gainers as of 9:05 am

via: SeekingAlpha at 2018-01-17 09:27:28:000

NURO +65% on deal with Glaxo for Quell ex-U.S. More news on: NeuroMetrix, Inc., Juno Therapeutics, AEterna Zentaris, Inc., Stocks on the move, Read more … read more...

Premarket Gainers as of 9:05 am

via: SeekingAlpha at 2018-01-17 09:27:28:000

NURO +65% on deal with Glaxo for Quell ex-U.S. More news on: NeuroMetrix, Inc., Juno Therapeutics, AEterna Zentaris, Inc., Stocks on the move, Read more … read more...

Premarket Gainers as of 9:05 am

via: SeekingAlpha at 2018-01-17 09:27:28:000

NURO +65% on deal with Glaxo for Quell ex-U.S. More news on: NeuroMetrix, Inc., Juno Therapeutics, AEterna Zentaris, Inc., Stocks on the move, Read more … read more...

Premarket Gainers as of 9:05 am

via: SeekingAlpha at 2018-01-17 09:27:28:000

NURO +65% on deal with Glaxo for Quell ex-U.S. More news on: NeuroMetrix, Inc., Juno Therapeutics, AEterna Zentaris, Inc., Stocks on the move, Read more … read more...

Premarket Gainers as of 9:05 am

via: SeekingAlpha at 2018-01-17 09:27:28:000

NURO +65% on deal with Glaxo for Quell ex-U.S. More news on: NeuroMetrix, Inc., Juno Therapeutics, AEterna Zentaris, Inc., Stocks on the move, Read more … read more...

Aeterna Zentaris shares halted pending news

via: SeekingAlpha at 2018-01-17 07:00:55:000

Nasdaq has suspended trading in Aeterna Zentaris (NASDAQ: AEZS ) pending the release of news. More news on: AEterna Zentaris, Inc., Strongbridge Biopharma, Healthcare stocks news, Stocks on the move, Read more … read more...

Aeterna Zentaris shares halted pending news

via: SeekingAlpha at 2018-01-17 07:00:55:000

Nasdaq has suspended trading in Aeterna Zentaris (NASDAQ: AEZS ) pending the release of news. More news on: AEterna Zentaris, Inc., Strongbridge Biopharma, Healthcare stocks news, Stocks on the move, Read more … read more...

Aeterna Zentaris shares halted pending news

via: SeekingAlpha at 2018-01-17 07:00:55:000

Nasdaq has suspended trading in Aeterna Zentaris (NASDAQ: AEZS ) pending the release of news. More news on: AEterna Zentaris, Inc., Strongbridge Biopharma, Healthcare stocks news, Stocks on the move, Read more … read more...

Aeterna Zentaris shares halted pending news

via: SeekingAlpha at 2018-01-17 07:00:55:000

Nasdaq has suspended trading in Aeterna Zentaris (NASDAQ: AEZS ) pending the release of news. More news on: AEterna Zentaris, Inc., Strongbridge Biopharma, Healthcare stocks news, Stocks on the move, Read more … read more...

Aeterna Zentaris shares halted pending news

via: SeekingAlpha at 2018-01-17 07:00:55:000

Nasdaq has suspended trading in Aeterna Zentaris (NASDAQ: AEZS ) pending the release of news. More news on: AEterna Zentaris, Inc., Strongbridge Biopharma, Healthcare stocks news, Stocks on the move, Read more … read more...

Your Daily Pharma Scoop: Biogen Setback, Ironwood Commences Trial, Vtv Signs 2 Deals

via: SeekingAlpha at 2017-12-23 11:37:46:000

Analysis of top Seeking Alpha coverage: Biogen Today we will focus on Biogens ( BIIB ) announcement regarding BAN2401, the companys Alzheimers candidate in mid-stage study. Biogen shares dropped more than 3% on Thursday after the company said that an Independent D… read more...

Your Daily Pharma Scoop: Biogen Setback, Ironwood Commences Trial, Vtv Signs 2 Deals

via: SeekingAlpha at 2017-12-23 11:37:46:000

Analysis of top Seeking Alpha coverage: Biogen Today we will focus on Biogens ( BIIB ) announcement regarding BAN2401, the companys Alzheimers candidate in mid-stage study. Biogen shares dropped more than 3% on Thursday after the company said that an Independent D… read more...

Your Daily Pharma Scoop: Biogen Setback, Ironwood Commences Trial, Vtv Signs 2 Deals

via: SeekingAlpha at 2017-12-23 11:37:46:000

Analysis of top Seeking Alpha coverage: Biogen Today we will focus on Biogens ( BIIB ) announcement regarding BAN2401, the companys Alzheimers candidate in mid-stage study. Biogen shares dropped more than 3% on Thursday after the company said that an Independent D… read more...

Your Daily Pharma Scoop: Biogen Setback, Ironwood Commences Trial, Vtv Signs 2 Deals

via: SeekingAlpha at 2017-12-23 11:37:46:000

Analysis of top Seeking Alpha coverage: Biogen Today we will focus on Biogens ( BIIB ) announcement regarding BAN2401, the companys Alzheimers candidate in mid-stage study. Biogen shares dropped more than 3% on Thursday after the company said that an Independent D… read more...

Your Daily Pharma Scoop: Biogen Setback, Ironwood Commences Trial, Vtv Signs 2 Deals

via: SeekingAlpha at 2017-12-23 11:37:46:000

Analysis of top Seeking Alpha coverage: Biogen Today we will focus on Biogens ( BIIB ) announcement regarding BAN2401, the companys Alzheimers candidate in mid-stage study. Biogen shares dropped more than 3% on Thursday after the company said that an Independent D… read more...

Biotech Forum Daily Digest: Synergy's CEO Leaves, Shareholders Cheer!

via: SeekingAlpha at 2017-12-22 11:51:39:000

I love deadlines. I love the whooshing noise they make as they go by . Douglas Adams, The Salmon of Doubt Another trading day, another record close for the major indices on Thursday. While the biotech sector is more than five percent off from its recent highs to end th… read more...

Biotech Forum Daily Digest: Synergy's CEO Leaves, Shareholders Cheer!

via: SeekingAlpha at 2017-12-22 11:51:39:000

I love deadlines. I love the whooshing noise they make as they go by . Douglas Adams, The Salmon of Doubt Another trading day, another record close for the major indices on Thursday. While the biotech sector is more than five percent off from its recent highs to end th… read more...

Biotech Forum Daily Digest: Synergy's CEO Leaves, Shareholders Cheer!

via: SeekingAlpha at 2017-12-22 11:51:39:000

I love deadlines. I love the whooshing noise they make as they go by . Douglas Adams, The Salmon of Doubt Another trading day, another record close for the major indices on Thursday. While the biotech sector is more than five percent off from its recent highs to end th… read more...

Biotech Forum Daily Digest: Synergy's CEO Leaves, Shareholders Cheer!

via: SeekingAlpha at 2017-12-22 11:51:39:000

I love deadlines. I love the whooshing noise they make as they go by . Douglas Adams, The Salmon of Doubt Another trading day, another record close for the major indices on Thursday. While the biotech sector is more than five percent off from its recent highs to end th… read more...

Biotech Forum Daily Digest: Synergy's CEO Leaves, Shareholders Cheer!

via: SeekingAlpha at 2017-12-22 11:51:39:000

I love deadlines. I love the whooshing noise they make as they go by . Douglas Adams, The Salmon of Doubt Another trading day, another record close for the major indices on Thursday. While the biotech sector is more than five percent off from its recent highs to end th… read more...

Midday Gainers / Losers

via: SeekingAlpha at 2017-12-21 12:47:15:000

Gainers: LTEA +177% . NXTD +120% . AEZS +47% . JTPY +49% . GNRT +30% . NETE +21% . ERJ +23% . SAEX +18% . HSGX +18% . MICT +17% . More news on: Long Island Iced Tea Corp., NXT-ID Inc., AEterna Zentaris, Inc., Stocks on the move, Read more … read more...

Midday Gainers / Losers

via: SeekingAlpha at 2017-12-21 12:47:15:000

Gainers: LTEA +177% . NXTD +120% . AEZS +47% . JTPY +49% . GNRT +30% . NETE +21% . ERJ +23% . SAEX +18% . HSGX +18% . MICT +17% . More news on: Long Island Iced Tea Corp., NXT-ID Inc., AEterna Zentaris, Inc., Stocks on the move, Read more … read more...

Midday Gainers / Losers

via: SeekingAlpha at 2017-12-21 12:47:15:000

Gainers: LTEA +177% . NXTD +120% . AEZS +47% . JTPY +49% . GNRT +30% . NETE +21% . ERJ +23% . SAEX +18% . HSGX +18% . MICT +17% . More news on: Long Island Iced Tea Corp., NXT-ID Inc., AEterna Zentaris, Inc., Stocks on the move, Read more … read more...

Midday Gainers / Losers

via: SeekingAlpha at 2017-12-21 12:47:15:000

Gainers: LTEA +177% . NXTD +120% . AEZS +47% . JTPY +49% . GNRT +30% . NETE +21% . ERJ +23% . SAEX +18% . HSGX +18% . MICT +17% . More news on: Long Island Iced Tea Corp., NXT-ID Inc., AEterna Zentaris, Inc., Stocks on the move, Read more … read more...

Midday Gainers / Losers

via: SeekingAlpha at 2017-12-21 12:47:15:000

Gainers: LTEA +177% . NXTD +120% . AEZS +47% . JTPY +49% . GNRT +30% . NETE +21% . ERJ +23% . SAEX +18% . HSGX +18% . MICT +17% . More news on: Long Island Iced Tea Corp., NXT-ID Inc., AEterna Zentaris, Inc., Stocks on the move, Read more … read more...

Your Daily Pharma Scoop: AEterna Zentaris Gets FDA Nod, Valeant Finalizes Sprout Sale, Roche Gets EC Approval

via: SeekingAlpha at 2017-12-21 09:42:09:000

Content Analysis of coverage: AEZS Stocks in the news: Analyst Ratings Insider Sales Insider Purchases Secondary Offerings Earnings Report Earnings Calendar Catalyst Rundown Analysis of top Seeking Alpha coverage: AEterna Zentaris Today we will foc… read more...

Your Daily Pharma Scoop: AEterna Zentaris Gets FDA Nod, Valeant Finalizes Sprout Sale, Roche Gets EC Approval

via: SeekingAlpha at 2017-12-21 09:42:09:000

Content Analysis of coverage: AEZS Stocks in the news: Analyst Ratings Insider Sales Insider Purchases Secondary Offerings Earnings Report Earnings Calendar Catalyst Rundown Analysis of top Seeking Alpha coverage: AEterna Zentaris Today we will foc… read more...

Your Daily Pharma Scoop: AEterna Zentaris Gets FDA Nod, Valeant Finalizes Sprout Sale, Roche Gets EC Approval

via: SeekingAlpha at 2017-12-21 09:42:09:000

Content Analysis of coverage: AEZS Stocks in the news: Analyst Ratings Insider Sales Insider Purchases Secondary Offerings Earnings Report Earnings Calendar Catalyst Rundown Analysis of top Seeking Alpha coverage: AEterna Zentaris Today we will foc… read more...

Your Daily Pharma Scoop: AEterna Zentaris Gets FDA Nod, Valeant Finalizes Sprout Sale, Roche Gets EC Approval

via: SeekingAlpha at 2017-12-21 09:42:09:000

Content Analysis of coverage: AEZS Stocks in the news: Analyst Ratings Insider Sales Insider Purchases Secondary Offerings Earnings Report Earnings Calendar Catalyst Rundown Analysis of top Seeking Alpha coverage: AEterna Zentaris Today we will foc… read more...

Your Daily Pharma Scoop: AEterna Zentaris Gets FDA Nod, Valeant Finalizes Sprout Sale, Roche Gets EC Approval

via: SeekingAlpha at 2017-12-21 09:42:09:000

Content Analysis of coverage: AEZS Stocks in the news: Analyst Ratings Insider Sales Insider Purchases Secondary Offerings Earnings Report Earnings Calendar Catalyst Rundown Analysis of top Seeking Alpha coverage: AEterna Zentaris Today we will foc… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2015-11-20 100.0 1.0 100.0
Data provided for free by IEX